Literature DB >> 12617988

Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice.

O Aguejouf1, K Mayo, L Monteiro, F Doutremepuich, C Doutremepuich, F Megraud.   

Abstract

An animal model was developed to study arterial thrombosis and determine if animals infected with Helicobacter pylori behave differently after induction of direct damage to blood vessels. Twenty-one C56/BL6 mice inoculated with the "Sydney strain" of H. pylori and 19 uninfected animals were kept for 1 year before testing. Vascular lesions were induced to mesenteric arterioles (15-25 microm diameter) by Argon laser. The dynamic course of thrombus formation was continuously monitored by a video camera for 10 min. Three parameters were assessed: (1) the number of laser pulses required to induce thrombus formation, (2) the number of platelet emboli removed by the blood flow and, (3) the duration of embolization. Additionally, blood was tested for platelet aggregation, fibrinogen, and cell count. Of the parameters measured, statistical differences between infected and uninfected mice concerned the number of emboli formed (6.00+/-2.18 infected vs. 3.89+/-1.37 non-infected, p=.0006) and the duration of embolization (2.41+/-0.73 min infected vs. 1.47+/-0.61 min non-infected p>.0001). A significant difference was also found in the fibrinogen levels between infected and uninfected mice. Chronic infection of mice with H. pylori leads to increased platelet embolization after damage to arterioles. These results are in favor of the possible involvement of H. pylori infection in the acute phase of coronary heart disease (CHD).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12617988     DOI: 10.1016/s0049-3848(03)00006-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Helicobacter pylori and coronary artery disease: which is the better target population?

Authors:  Rinaldo Pellicano; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.199

2.  Putative consequences of exposure to Helicobacter pylori infection in patients with coronary heart disease in terms of humoral immune response and inflammation.

Authors:  Agnieszka Matusiak; Maciej Chałubiński; Marlena Broncel; Tomasz Rechciński; Karolina Rudnicka; Eliza Miszczyk; Maria Walencka; Dominik Strapagiel; Adrian Gajewski; Magdalena Chmiela
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

3.  Impact of Helicobacter pylori eradication timing on the risk of thromboembolism events in patients with peptic ulcer disease: a population-based cohort study.

Authors:  Jung-Nien Lai; Yi-Jun Liao; Cheng-Li Lin; Chi-Sen Chang; Yen-Chun Peng
Journal:  BMJ Open       Date:  2022-08-24       Impact factor: 3.006

Review 4.  Antiphospholipid syndrome infectious origin.

Authors:  M Blank; R A Asherson; R Cervera; Y Shoenfeld
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.542

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.